Focuses of this update are: Barrier systems (RABS and isolators) for sterile manufacturing and manufacture of terminally sterilised products
The following overview lists the topics covered with this Update:
GMP in Practice
Chapter 3 Premises
- 3.F Barrier systems (RABS and isolators) for sterile manufacturing
Chapter 12 Sterile Production
- 12.C Manufacture of terminally sterilised products
GMP Regulations
Chapter C EU Directives and Guidelines
- C.7 Compilation of Union Procedures on Inspections and Exchange of Information
- C.19 Questions and answers for marketing authorisation holders/applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products
Chapter E ICH Guidelines
- E.2 ICH Q2(R2) Validation of Analytical Procedures
- E.5.A ICH Q5A(R2) Viral Safety Evaluation of Biotechnology Products Derived From Cell Lines of Human or Animal Origin
- E.14 ICH Q14 Analytical Procedure Development
To the knowledge portal
More info on the GMP Compliance Adviser